Profitelligence Profitelligence · Filing Ledger Open A research →

Form 8-K · Current Report · Filed 2025-03-03

Agilent Technologies Announces Organizational Restructuring

Agilent Technologies, Inc. announced a reorganization of its business structure effective November 2024, resulting in the formation of three new segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The changes are reflected in the recast of certain items in the Annual Report on Form 10-K. This Current Report on Form 8-K includes financial statements and exhibits that support the updated segment information.

Filer
Agilent Technologies Inc. A · NYSE
Filed
Accession
0001090872-25-000010
CIK
0001090872
Signal
Low impactHealthcare

Items reported

Item 8.01

Other Events

Corporate Update
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$127.92

Next session

-3.8%

Since filing

+8.2%

Latest close

$138.37

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from A reporting the same item, with the next session's move:

Exhibits (2)

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another A filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts